Sanofi (SNYNF) Operating Margin (2009 - 2026)

Sanofi (SNYNF) posted Operating Margin of 120.56% for Q2 2026, up 4.02% sequentially from 115.9% in Q1 2026, and up 113.0% YoY from 56.6% in Q2 2025.

Sanofi (SNYNF) Operating Margin (2009 - 2026) Analysis & Trends

Sanofi has reported Operating Margin for 18 years, with the latest figure at 120.56% in Q2 2026.

Quarterly Operating Margin rose 113.0% year-over-year to 120.56% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 161.46% (up 896.0% YoY) and the FY2025 annual result came in at 14.54%, down 311.0% from the prior year.
Operating Margin rose to 120.56% in Q2 2026 per SNYNF's latest filing, from 115.9% in the prior quarter.
Over five years, Operating Margin peaked at 340.95% in Q4 2024 and troughed at 120.82% in Q4 2025.
A 5-year average of 115.43% and a median of 116.76% in 2023 frame the typical range for Operating Margin.
The sharpest annual moves came in 2024 and 2025: Operating Margin jumped 22347 bps in 2024, then slumped 46178 bps in 2025.
Over 5 years, Operating Margin stood at 121.92% in 2022, then fell by 4 bps to 117.49% in 2023, then surged by 190 bps to 340.95% in 2024, then slumped by 135 bps to 120.82% in 2025, then jumped by 200 bps to 120.56% in 2026.
According to Business Quant data, Operating Margin over the past three periods registered 120.56%, 115.9%, and 120.82% for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data